Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma.
about
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaImmunotherapy strategies for multiple myeloma: the present and the futureHeat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protectionNeuroblastoma: developmental biology, cancer genomics and immunotherapy.Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastomaComparison of stimulating effect on subpopulations of lymphocytes in human peripheral blood by methionine enkephalin with IL-2 and IFN-γ.Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceImmunology and immunotherapy of neuroblastomaProgrammed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.Immunocombination therapy for high-risk neuroblastoma.Immunosuppressive microenvironment in neuroblastoma.The graft-versus-neuroblastoma effect of allogeneic hematopoietic stem cell transplantation, a review of clinical and experimental evidence and a perspective on mechanisms.New immunotherapeutic strategies for the treatment of neuroblastoma.Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibitionA transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.Examining T cells at vaccine sites of tumor-bearing hosts provides insights to dysfunctional T-cell immunity.IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition.Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma.
P2860
Q26770306-BE6CA379-F51B-450D-A6E6-D6F17B4751D9Q27021939-9A620C26-E05A-4D56-9661-8D1496C38516Q33585305-05896238-3D5A-42BE-91DA-F1DD97DD35F4Q33724352-043C0BD5-C129-4CF2-8A5A-F8040D52C767Q34339707-B60C9B1D-2C5C-4554-BDE2-9C5D0AAF122AQ35283020-3A6ACC13-9AA6-40D0-8986-F2097776E1F0Q35747826-9FD8501C-7458-4837-A6D3-0A067BAF31FEQ36552894-DDBAA9A5-BCE5-4E90-9BAE-D901290AEAD6Q36555546-54A13D35-B08F-48B1-A8A5-B5CC79635939Q36856798-123511BD-1162-430F-82B6-1938FF13BA97Q37478912-7C9A2E45-E111-4C48-A197-8C71BFA46F0CQ37991024-6361F3EC-F4E7-44E3-954A-F654A73850F0Q38117379-1A2B91D6-C348-4FE6-86CD-CEBE8C986F96Q38243215-96A013B9-EE4B-4B91-8FB3-533A3BE1DE80Q38389316-64373540-48CB-4F2C-92F1-249BE9FD1D7CQ39085608-24F0AFF5-D444-49EB-950E-2475FDB1A36EQ39095788-B5E3CFB7-AEE8-4C19-A4AB-151633019582Q39232427-845C5705-8C40-450F-8720-50CD4BB6CB64Q40190430-145970E5-55A2-40BA-8321-DB0425D39E54Q41579154-EAA49DBF-409C-4DE9-912C-BA37E9599771Q42152303-3C983713-87A9-4FF8-81FD-FF09182E2674Q52717590-A7764E19-8BF8-4D45-9937-5A14B1FE9EEA
P2860
Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@en
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@nl
type
label
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@en
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@nl
prefLabel
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@en
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@nl
P2093
P2860
P1433
P1476
Depletion of CD25⁺ T cells fro ...... ced immunity to neuroblastoma.
@en
P2093
Bryon D Johnson
Jill A Gershan
Weiqing Jing
William H D Hallett
Xiaocai Yan
P2860
P304
P356
10.1182/BLOOD-2010-12-326108
P407
P577
2011-04-26T00:00:00Z